Verrica Pharmaceuticals Inc. (VRCA)
NASDAQ: VRCA · Real-Time Price · USD
0.4946
-0.0503 (-9.23%)
At close: May 30, 2025, 4:00 PM
0.4971
+0.0025 (0.51%)
After-hours: May 30, 2025, 7:14 PM EDT
Verrica Pharmaceuticals Employees
Verrica Pharmaceuticals had 71 employees as of December 31, 2024. The number of employees decreased by 29 or -29.00% compared to the previous year.
Employees
71
Change (1Y)
-29
Growth (1Y)
-29.00%
Revenue / Employee
$101,113
Profits / Employee
-$929,437
Market Cap
45.75M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
VRCA News
- 4 days ago - Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York - GlobeNewsWire
- 18 days ago - Verrica Pharmaceuticals, Inc. (VRCA) Q1 2025 Corporate Update Conference Call - Seeking Alpha
- 18 days ago - Verrica Pharmaceuticals Reports Quarterly 2025 Financial Results - GlobeNewsWire
- 25 days ago - Verrica Pharmaceuticals to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 13, 2025 - GlobeNewsWire
- 4 weeks ago - Verrica Pharmaceuticals to Participate in the Citizens Life Sciences Conference in New York - GlobeNewsWire
- 2 months ago - Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors - GlobeNewsWire
- 2 months ago - Verrica Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 2 months ago - Verrica Pharmaceuticals Appoints Noah L. Rosenberg, M.D. - GlobeNewsWire